AstraZeneca types up $247M, AI-enabled oncology antibody design pact, joining Absci’s list of pharma allies – FierceBiotech
AstraZeneca types up $247M, AI-enabled oncology antibody design pact, joining Absci’s list of pharma allies – FierceBiotech